Gene-Editing heart treatment tracked for 15 years in new study
Disease control
ENROLLING_BY_INVITATION
This study follows 116 people who received an experimental gene-editing therapy for heart disease or high cholesterol. Researchers will monitor them for 15 years to see if any side effects appear and how their cholesterol levels change over time. The goal is to understand the lon…
Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:06 UTC